170 related articles for article (PubMed ID: 29188530)
41. Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.
Wang XF; Lin GS; Lin ZX; Chen YP; Chen Y; Zhang JD; Tan WL
Int J Clin Exp Pathol; 2014; 7(9):6133-40. PubMed ID: 25337261
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
43. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.
Kuhn SA; Martin M; Brodhun M; Kratzsch T; Hanisch UK; Haberl H
Neurol Res; 2014 Aug; 36(8):709-21. PubMed ID: 24620969
[TBL] [Abstract][Full Text] [Related]
45. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
[TBL] [Abstract][Full Text] [Related]
46. Functional and phenotypic differences between glioblastoma multiforme-derived and normal human brain endothelial cells.
Charalambous C; Hofman FM; Chen TC
J Neurosurg; 2005 Apr; 102(4):699-705. PubMed ID: 15871513
[TBL] [Abstract][Full Text] [Related]
47. Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas.
Okamoto S; Nitta M; Maruyama T; Sawada T; Komori T; Okada Y; Muragaki Y
Brain Tumor Pathol; 2016 Apr; 33(2):129-36. PubMed ID: 26826105
[TBL] [Abstract][Full Text] [Related]
48. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
[TBL] [Abstract][Full Text] [Related]
49. Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.
Takano S
Brain Tumor Pathol; 2012 Apr; 29(2):73-86. PubMed ID: 22218709
[TBL] [Abstract][Full Text] [Related]
50. The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.
Takano S; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Yamamoto T; Matsumura A
Int J Oncol; 2017 Feb; 50(2):515-524. PubMed ID: 28000842
[TBL] [Abstract][Full Text] [Related]
51. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
52. Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.
Matsuda Y; Hagio M; Ishiwata T
World J Gastroenterol; 2013 Jan; 19(1):42-8. PubMed ID: 23326161
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
54. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
55. Circulating endothelial progenitor cells in malignant gliomas.
Rafat N; Beck GCh; Schulte J; Tuettenberg J; Vajkoczy P
J Neurosurg; 2010 Jan; 112(1):43-9. PubMed ID: 19522573
[TBL] [Abstract][Full Text] [Related]
56. Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors.
Gupta K; Radotra BD; Banerjee AK; Nijhawan R
Anal Quant Cytol Histol; 2004 Aug; 26(4):223-9. PubMed ID: 15457675
[TBL] [Abstract][Full Text] [Related]
57. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Fukasawa M; Korc M
Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
[TBL] [Abstract][Full Text] [Related]
58. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
59. [Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia].
Wang C; Chen FY; Zhu JS; Xu YP; Han JY; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):845-8. PubMed ID: 15634546
[TBL] [Abstract][Full Text] [Related]
60. Angiogenic effect of thymidine phosphorylase on macrophages in glioblastoma multiforme.
Hirano H; Tanioka K; Yokoyama S; Akiyama S; Kuratsu J
J Neurosurg; 2001 Jul; 95(1):89-95. PubMed ID: 11455962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
